<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, there are symptoms not only of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> but also of <z:e sem="disease" ids="C0013985" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional disturbance</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Postmortem human brain studies have shown a disturbed metabolism of <z:chebi fb="19" ids="28790">serotonin</z:chebi> and overactivity of neuroendocrine-controlling factors in the hypothalamus </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with a selective <z:chebi fb="0" ids="28790">5-HT</z:chebi> reuptake blocker, <z:chebi fb="0" ids="3723">citalopram</z:chebi>, causes a significant reduction in postdexamethasone <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="3723">Citalopram</z:chebi> in patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> disorders produces no improvement in psychomotor and cognitive behavior, but symptoms of <z:e sem="disease" ids="C0013985" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional disturbance</z:e> are reduced </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="3723">Citalopram</z:chebi> does not have a pure antidepressant effect; rather, the drug is considered an emotional stabilizer </plain></SENT>
</text></document>